Previous 10 | Next 10 |
Financial News Media news releases related Financial News Media news releases and Financial News Media press releases from 01/10/24 08:45:50 on US and...
2024-01-10 08:45:50 ET Palm Beach, FL – January 10, 2024 – FN Media Group News Commentary – Nuclear power is becoming a more dependable and scalable energy source due to the world’s growing demand for electricity, particularly in emerging economies. T...
2024-01-10 08:45:50 ET Palm Beach, FL – January 10, 2024 – FN Media Group News Commentary – Nuclear power is becoming a more dependable and scalable energy source due to the world’s growing demand for electricity, particularly in emerging economies. T...
2024-01-10 08:45:50 ET Palm Beach, FL – January 10, 2024 – FN Media Group News Commentary – Nuclear power is becoming a more dependable and scalable energy source due to the world’s growing demand for electricity, particularly in emerging economies. T...
2024-01-10 08:30:36 ET NetworkNewsWire Editorial Coverage New York, NY – January 10, 2024 – On Sept. 20, 2019, history was made when the U.S. Food and Drug Administration approved Rybelsus as the first oral glucagon-like peptide-1 (GLP-1) agonist for type 2 dia...
2024-01-10 08:30:36 ET NetworkNewsWire Editorial Coverage New York, NY – January 10, 2024 – On Sept. 20, 2019, history was made when the U.S. Food and Drug Administration approved Rybelsus as the first oral glucagon-like peptide-1 (GLP-1) agonist for type 2 dia...
2024-01-10 08:30:36 ET NetworkNewsWire Editorial Coverage New York, NY – January 10, 2024 – On Sept. 20, 2019, history was made when the U.S. Food and Drug Administration approved Rybelsus as the first oral glucagon-like peptide-1 (GLP-1) agonist for type 2 dia...
2024-01-10 08:30:36 ET NetworkNewsWire Editorial Coverage New York, NY – January 10, 2024 – On Sept. 20, 2019, history was made when the U.S. Food and Drug Administration approved Rybelsus as the first oral glucagon-like peptide-1 (GLP-1) agonist for type 2 dia...
2024-01-10 08:30:36 ET NetworkNewsWire Editorial Coverage New York, NY – January 10, 2024 – On Sept. 20, 2019, history was made when the U.S. Food and Drug Administration approved Rybelsus as the first oral glucagon-like peptide-1 (GLP-1) agonist for type 2 dia...
2024-01-09 10:25:55 ET Palm Beach, FL – January 9, 2024 – According to the report titled “Aging in the United States,” published by the Population Reference Bureau, “the number of Americans aged 65 and older is projected to increase more than double over 9...
2024-01-09 10:25:55 ET Palm Beach, FL – January 9, 2024 – According to the report titled “Aging in the United States,” published by the Population Reference Bureau, “the number of Americans aged 65 and older is projected to increase more than double over 9...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
100.0%Change Percent:
Bayer AG Registered Shares Company Name:
BAYZF Stock Symbol:
OTCMKTS Market: